This is a preview of subscription content, log in via an institution to check access.
Literatur
Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. New Engl J Med 1996;334:488–93.
Conte PF, Latreille J, Mauriac L, et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. J Clin Oncol 1996;14:2552–9.
Fleisch H. Bisphosphonates in bone disease, 2nd edn, New York-London. Parthenon, 1995.
Hortobagvi GN, Theriault RL, Lester Porter DO, et al. (for the Protocol 19 Aredia Breast Cancer Study Group). Efficacy of pamidronate in reducing skeletal complications in patients with breat cancer and lytic bone metastases. New Engl J Med 1996;335:1785–91.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adamietz, I.A. Verzögerung der Progredienz von Knochenmetastasen bei Mammakarzinompatientinnen durch intravenöse Pamidronat-behandlung: Ergebnisse einer randomisierten, kontrollierten, multinationalen Studie. Strahlenther Onkol 174, 438 (1998). https://doi.org/10.1007/BF03038568
Issue Date:
DOI: https://doi.org/10.1007/BF03038568